Overexpression of miR-125 reduces the expression of mesenchymal phenotype-related genes including VEGF, N-cadherin, and vimentin, which results in inhibiting the proliferation and migration of hepatoma cells (Zha and Li, 2020). Here, CDH2 is linked to hepatocellular carcinoma.